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Results: A total 30 cases in the age group of 14 to 57 years (median
age of 28 years) were studied.
Out of the 30 cases 27 were males and remaining 3 were fe-
males. In 25 cases out of 30 (83%), the Femoral Vein was medial to
Artery. In 5 cases (17%) the Femoral Vein was Postero-medial to
the femoral artery. Among the 5 cases 2 cases had more than 50%
overlap. No one had femoral vein completely posterior to femoral
artery. In our study themean Femoral artery size was 7.3 mm (SD-
1.4) in Antero-posterior dimension and 7.5 mm (SD -1.4) in hori-
zontal dimension. This has important implications while cannu-
lating the artery for vascular access.
Conclusion: We conclude that there is a distinct variation in the
anatomical location of the femoral artery and vein. In 17% of in-
dividuals the vein is located Postero-medial to the artery, among
them one third have significant overlap (>50%) of artery and vein.
This may have implicate during the femoral artery access.
Safety and efficiency of eptifibatide in primary
angioplasty patients with renal insufficiency
V.S.R. Bhupal, M. Jyotsna, D. Seshagiri Rao
Nizam's Institue of Medical Sciences, Hyderabad, India
Aim: Eptifibatide adjustment of dosage is required in renal
insufficiency patients. But when we do not know the renal status
in primary angioplasty patients with significant intracoronary
thrombus, wewant to study the safety and efficacy of normal dose
of Eptifibatide.
Methods: We analyzed the Patients who had Primary angioplasty
with significant intracoronary thrombus with renal insufficiency
(calculated GFR < 60 ml/min) and received bolus dose of Eptifi-
batide 180 microgram/kg followed by infusion of 2.0 microgram/
kg/min for 12 hours. All patients in addition received loading
dose of clopidogrel 600mg and Aspirin 325 mg. In all patients
Platelet aggregation was tested after Primary angioplasty with
chronology dual aggregometer (optical density dependent) with
ADP (sustained inhibition of 10 mmol/L ADP induced aggregation).
After knowing the basal serum creatinine levels, Glomerular
filtration rate (GFR) was calculated using Cockroft & Gault for-
mula (140-Age (yrs)) weight (Kgs) / S.creatinineX72 *(X0.85
correction for women).
Results: Number of primary angioplasty patients who received
Eptifibatide who’s GFR is <60 ml/min were 53 patients. Males
were 43 and females were 10 with mean age of 59±10 years. Out
of them only diabetics were 7 (13.2%), only hypertensive were 19
(35.9%) and both diabetic and hypertensive with or without
smoking in 27 (50.9%) patients. Mean platelet inhibition after
primary PCI was 95±2%. PCI to LAD in 23 (43.4%), LCX/ ramus in
10 (18.9%), RCA in 5 (9.4%) and two culprit lesions in 15 (28.3%)
patients were done. Mean GFR in this group was 45±9ml/min and
mean creatinine 1.6±0.4mg/dl. 2 (3.8%) patients had worsening of
pre existing CKD possibly related to contrast (in both cases serum
creatinine shooted to 2 mg/dl). Both of them recovered without
any need for dialysis. Nne had either puncture site or non-
puncture bleeding. Six patients required IABP and 2 required
temporary pacing.
Conclusion: Even though we do not know the underlying renal
status in primary angioplasty pts (who really have renal insuffi-
ciency) we can give routine dose of Eptifibatide to maintain effi-
ciency without compromising safety.
Drug eluting balloon evaluation in de-novo non-
LAD stenoses
J.S. Hiremath, K.S. Sheth, C.N. Makhale
Ruby Hall Clinic, Pune, India
Background: Drug eluting balloons (DEB) are preferred therapy in
cases of In-stent restenosis. However their efficacy in cases of de-
novo lesions is yet to be acceptably established.
Methods: 25 random individuals with de-novo non eLAD critical
stenoses (>70% angiographic stenosis) underwent coronary an-
gioplasty with Sequent Please (Paclitaxel Eluting) Balloon between
11 May 2012 to 18 December 2012.Additional lesions in other
coronaries were treated in the same sitting with drug eluting or
bare metal stents. At 9 month post-procedure, all underwent
coronary angiography irrespective of the symptoms.
Results: Twenty five lesions were treatedwith DEB. DEB procedure
was successful in all patients. One required stenting with DES due
to dissection.At 9month angiographic follow-up, all patients were
free of angina. One patient had critical restenosis. Incidentally 2
patients had in-stent restenosis in BMS and DES in other vessels
but DEB segment was widely patent.
Our study group had 100% procedural success (DEB) with 96%
post-procedure patency rate at nine month angiographic follow-
up. Complication rate for the procedure was 4% (TIMIminor bleed)
and in-segment restenosis was 4%. During the same period,
restenosis rate for stents was 8% (2 in 24 stents) (Surprisingly
higher than DEB).
Conclusion: DEB in small to medium non eLAD critical stenoses is
safe and effective procedure.
Efficiency of bivalirudin in improving coronary
flow in obstructive coronary artery disease
patients
K. Sridhar Babu, M. Jyotsna, D. Seshagiri Rao
Nizams Institute of Medical Sciences, Hyderabad, India
Aim: To see whether Bivalirudin alone improve the coronary flow
before PCI.
Methods: We prospectively recruited patients of acute coronary
syndrome (ACS) excluding ST elevation MI with single significant
coronary stenosis (not complete occlusion) undergoing percuta-
neous coronary intervention (PCI). Immediately after basal culprit
vessel angiogram in a appropriate view, Bivalirudin 0.75 mg/kg
intravenous bolus followed by a 1.75kg/mg hour infusion was
started. Then again in same previous view culprit vessel angio-
gram was repeated 3 minutes after stating the Bivallirudin infu-
sion. TIMI frame count was taken as indicator of coronary flow.
TIMI fram count (till the last segment of that particular vessel) of
culprit vessel was noted from angiogram at basal and after Biva-
lirudin injection. We excluded the angio analysis of cases where
there is improper engagement of guide catheter or guide sizes
other than 6F.
Results: In 50 eligible ACS patients lesion was in LAD in 23 (46%),
LCX in 15 (30%) and RCA in 12(24%). Mean TIMI frame count before
Bivalirudin was 16.92± 6.2 vs 11.4±3.8 , three minutes after start-
ing the Bivalirudin infusion which is statistically significant (p¼<
0.0001). There were no PCI procedure related complications like
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) s 1es 1 4 3S106
acute closure, slow or no flow, acute stent thrombosis in any pt.
So, also no puncture site or non-puncture site major or minor
bleeds.
Conclusion: Bivalirudin seems to improve TIMI frame counts
before angioplasty. Further studies are required to confirm and to
postulate the mechanism of improvement of TIMI frame counts.
Antegrade corsair usage in mild/moderate calcific
coronary chronic total occlusions
K. Sridhar Babu, M. Jyotsna, D. Seshagiri Rao
Nizams Institute of Medical Sciences, Hyderabad, India
Background: As a supporting catheter in CTO PCI, Fine cross
micro-catheter is preferred for Antegrade and Corsair micro-
catheter for Retrograde route. Corsair may malfunction in calcific
coronary lesions.
Aim: As the Corsair has tapered tip and good tractability in
tortuous vessels we want to see the efficiency and safety of
Corsair in mid/moderately calcific Antegrade second attempt CTO
PCI.
Methods: We did retrospective analysis of 15 mild/moderately
calcific, symptomatic patients Antegrade CTO PCI details (second
attempt) in whom corsair is used. Coronary calcification was
detected by flat panel digital detector fluoroscopic system (FPDD).
Results: Out of 15 patients, 12 were males, with mean age of 59.7
yrs and historically CTO duration was varying from 1 to 11 yrs.
Total no of lesions treated were 22 in 15 pts, 15 CTOs and 7 other
vessel lesions and majority of lesions were in RCA 7 (46.7%).
Average amount of contrast, fluoroscopic and procedural times
were 146±20ml, 33.6±10.2 minutes and 63.2±30.9 minutes
respectively. Unfavourable CTO lesion likemoderate calcium in 10
(66.7%) lesions, significant proximal vessel tortuosity in 5 (33.3%)
lesions, diffuse proximal disease in 3(20%), bent at occlusion in 4
(26.7%), bridging collaterals at occlusion in 3 (20%) and side branch
at occlusion were present in 9 (60%) lesions. None of cases showed
any distortion or fracture or entrapment of the Corsair. In hospital
complication rate due to contrast nephropathy (one patient) and
MACCE at 9 months due to TVR (one patient) was 6.6%.
Conclusion: Corsair micro catheter is useful in crossing the mild/
moderate complex selected calcific Antegrade CTO PCI with low in
hospital complications.
Direct culprit vessel primary PCI to LAD followed
by contra lateral angiography by transradial route
in acute myocardial infarction e Direct Study
Tapan Ghose, Supratiksh Yadav, Kuldeep Arora
Paras Hospital, Gurgaon, India
Background: Percutaneous coronary intervention (PCI) of the
infarct related artery (IRA) during primary PCI for ST elevation
myocardial infarction (STEMI) is appropriate. Two retrospective
analyses suggested that, direct PCI to the IRA without knowledge
of the anatomy of the contra lateral artery is feasible .This
approach would shorten the door to balloon time which is a
validated surrogate for mortality in AMI. We have reported the
feasibility in a pilot study (Direct prospective Pilot study). In the
presentstudy we tested the hypothesis that in anterior STEMI,
direct PCI to left anterior descending (LAD) artery before right
coronary artery angiography is feasible and this would shorten
the door to balloon (d2b) time.
Methods: Anterior wall STEMI was diagnosed by standard criteria.
All consecutive patients of anterior MI admitted between March
2012 and April 2014 were studied prospectively. Patients with
cardiogenic shock were excluded. Patients were treated with
aspirin 150 to 325 mg, ticagrelor 180 mg and atorvastatin 80 mg
and shifted to cath lab. Radial access was obtained by anterior
wall puncture. LMCA was hooked with 6F XB guiding catheter and
primary PCI to LAD was done as per standard protocol. After
successful PCI to LAD, the RCA angiogramwas performed with a 5
F TF catheter. All the intervals were recorded.
Results: 41 patients of anterior MI were treated. 30 DES and 12 BVS
were deployed. Themedian d2b timewas 35+11.8minutes and the
mean d2b time was 36.46+14.3min. Prior RCA angiogram would
have prolonged themedian d2b time by 2.45 minutes (p¼0.05) and
mean d2b time by 4.76 minutes (p¼<0.05).
Conclusion: From this multicenter study, we conclude that in
anterior wall STEMI, it is feasible to perform PCI to LAD directly
without knowing the RCA anatomy which significantly shortens
the d2b time. Randomized controlled trial is warranted.
Factors determining stent length & outcomes
K. Sridhar Babu, M. Jyotsna, D. Seshagiri Rao
Nizams Institute of Medical Sciences, Hyderabad, India
Background: In the previous studies it was shown that longer the
stent length more the chances of ISR .In the present study we
aimed to identify whether the stent length and type of stent and
risk factors determining the outcomes.
Methods: Retrospective analysis of 58 patients records who un-
derwent PCI were included. Patients were grouped into stent
length <15mm (G1)& Stent length(G2) >15mm. Analysis of various
factors determing stent length and its out come were done using
ANOVA test & regression analysis. Primary out comes were new
leisons & In Stent Restenosis.
Results: Mean age of the study population was 55 years and fe-
male were11, among them hypertensive patients were 39, di-
abetics were 31, and smokers were 16. Out of 58, acute coronary
syndromes (ACS) were 34 and total number of lesions was 76. PCI
was done through the radial puncture in 23 patients. Culprit
vessels were LAD in 29, LCX in 14, LMCA in 1, and rest RCA. Type of
lesions included B1 in 1, B2 in 45 and C in 12. In G1- 14 & G2 -42, of
which total events were 2 in G1 (P-0.14) & 11 in G2 (P-0.26). P value
of the two p-(0.3) gives there is no difference when total events vs
stent length (p¼0.3).
G1 had 2 new lesions & no ISR, G2 had 6 new lesions & 5 had ISR,
But significant difference in occurrence of ISR and stent length
(p¼0.02). BMS group -4 had new lesions& 1 ISR,&DES group-4 new
lesions & 4 ISR. If we see the type of stent either DES or BMS there
is no difference in occurrence of either ISR (p¼0.5) or total events
(0.34). General Regression Analysis: stent length versus age, He-
moglobin, PCV, DM etc showed DM (P-0.03), RBS(P-0.006), Type of
CAD(p-0.021) suggest that length of the stent is more in DM, hy-
perglycemic pts and ACS patients.
Conclusions: Most important factors determining stent length are
DM, new hyperglycemia and ACS status.
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